In analysis of all TP53 wild-type primary tumors across cancer, we computed the mean difference in PARADIGM scores between ARID1A mutant and ARID1A wild-type tumors (n = 492 and 4832, respectively) to determine pathway alterations associated with ARID1A mutation (Fig 5C). The gene discussed is TP53; the disease is cancer.